Among the underlying neuroendocrine alterations of low plasma GH levels in obesity, hormonal GHRH, somatostatin, or ghrelin dysregulation have been proposed (136, 139). Here, GH1 is linked to obesity due to melanocortin 4 receptor deficiency.